Analgesic Effect in Children of Low-Dose Ketamine for Mucositis Treated by Patient-Controlled Analgesia With Morphine
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
5 Years to 18 Years (Child, Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Child from 5 to 18 years.
Presenting mucitis induced by chemotherapy or a conditioning of graft hematopoïetic.
A pain not controlled by systematic paracetamol (10mg/kg/4h) or a the propacetamol (20mg/kg/4h).
Not presenting a neurological or psychological difficulty at the use of the PCA or a EVA.
First morphine amount going back to less 48h, and lass administration dating of more than 4h at the time of the beginning of the perfusion of Ketamine/placebo (EVA > 30 after stop morphine).
Assent signed by the parents and each time possible by the child.
The child was already included in the study.
The age of psychomotor development is lower than 5 years
Presence of a depression or a major depressive episode according to definition DSM IV.
Hepatic or renal anomaly major (rank 3 or 4 of the scale of toxicity NCI CTC v2.0)